Introduction to Drug Absorption and Delivery
Understanding how a drug moves from its dosage form into the systemic circulation is a cornerstone of pharmacology and pharmaceutical science. This course translates key concepts from a recent quiz into a comprehensive, SEO‑friendly guide. You will explore the Noyes‑Whitney equation, mechanisms of intestinal transport, the role of excipients in immediate‑release tablets, and the design principles behind modified‑release systems. By the end, you will be equipped to evaluate formulation strategies that optimize both dissolution and absorption.
The Noyes‑Whitney Equation and Dissolution Rate
The Noyes‑Whitney equation describes the rate at which a solid drug dissolves in a solvent:
Rate = (k × A × (S – C)) / h
where k is the dissolution constant, A is the surface area, S is the solubility, C is the concentration in the bulk medium, and h is the diffusion layer thickness. Among these variables, increasing the surface area (A) has the most direct impact on accelerating dissolution.
Practical ways to enlarge surface area
- Micronization or nanonization of the active pharmaceutical ingredient (API).
- Use of porous carriers that expose more drug particles to the dissolution medium.
- Grinding or spray‑drying techniques that produce fine powders.
Formulators often combine these tactics with solubility enhancers to achieve rapid drug release, especially for immediate‑release (IR) products.
Transport Mechanisms Across the Intestinal Epithelium
After dissolution, a drug must cross the intestinal barrier. The dominant pathway depends on both solubility and membrane permeability. A drug that is highly soluble but poorly permeable typically relies on paracellular diffusion, moving between the tight junctions of epithelial cells.
Key characteristics of paracellular diffusion
- Favours small, hydrophilic molecules.
- Limited by the size of tight junction pores (approximately 0.6–1.0 nm).
- Can be enhanced by permeation enhancers that transiently open tight junctions.
In contrast, lipophilic drugs with high membrane permeability primarily use passive transcellular diffusion, while larger or charged molecules may require carrier‑mediated active transport.
Excipient Selection for Immediate‑Release Formulations
Immediate‑release tablets aim to deliver 70‑80 % of the dose within the first hour. The excipient that most critically influences this rapid release is a superdisintegrant. These agents absorb water quickly, swell, and generate a force that breaks the tablet matrix apart.
Common superdisintegrants and their mechanisms
- Cross‑linked polyvinylpyrrolidone (cPVP) – swells dramatically upon wetting.
- Sodium starch glycolate – expands through a combination of swelling and wicking.
- croscarmellose sodium – utilizes a combination of capillary action and swelling.
Choosing the right type and concentration (typically 2–5 % w/w) ensures that the tablet disintegrates quickly, exposing a large surface area for dissolution.
Molecular Weight and Its Influence on Dissolution
Large molecules dissolve more slowly primarily because they possess a lower diffusion coefficient. According to the Stokes‑Einstein relationship, diffusion (D) is inversely proportional to the hydrodynamic radius of the molecule. As molecular weight increases, the molecule’s size grows, reducing D and consequently slowing the transport of drug molecules from the solid surface into the surrounding fluid.
Remembering the concept
- Mnemonic: “Big = slow” – a larger rock rolls slower than a pebble.
- Visual tip: Imagine a crowded hallway; tall people (large molecules) take longer to navigate through the crowd than short people (small molecules).
Formulators can mitigate this effect by reducing particle size, using amorphous solid dispersions, or adding surfactants that lower interfacial tension.
Simulating Gastric pH in In‑Vitro Dissolution Testing
To mimic the acidic environment of the stomach, the most effective adjustment is modifying the pH of the dissolution medium. Typical simulated gastric fluids are set to pH 1.2–3.0 using hydrochloric acid or acetate buffers.
Other dissolution parameters (for context)
- Rotation speed of the paddle – influences hydrodynamics but does not replicate pH.
- Volume of the vessel – affects sink conditions but not acidity.
- Temperature – usually maintained at 37 °C to reflect body temperature.
Accurate pH control is essential for drugs whose solubility is pH‑dependent, such as weak acids or bases, because it directly impacts the S term in the Noyes‑Whitney equation.
Delayed‑Release (Enteric) Drug Delivery Systems
A formulation that releases its active ingredient only after passing through the acidic stomach is classified as a delayed‑release system. These dosage forms are typically coated with an enteric polymer that remains intact at low pH and dissolves at the higher pH of the small intestine (pH > 5.5).
Key benefits of delayed release
- Protects acid‑labile drugs from gastric degradation.
- Reduces gastric irritation for drugs that are locally irritating.
- Targets drug release to the intestine where absorption may be more favorable.
It is important not to confuse delayed release with extended‑release (ER) formulations, which are designed to prolong drug exposure over time rather than to bypass the stomach.
Ester Hydrolysis: A Common Degradation Pathway
Drugs containing ester functional groups are especially susceptible to hydrolysis during storage. Water molecules attack the carbonyl carbon, cleaving the ester bond and producing an acid and an alcohol. This reaction is accelerated by moisture, elevated temperature, and extreme pH.
Stabilization strategies
- Incorporate desiccants in the packaging to limit moisture exposure.
- Use moisture‑resistant coatings or blister packs.
- Formulate with buffers that maintain a neutral pH, reducing the catalytic effect of acidic or basic conditions.
Understanding the hydrolytic vulnerability of ester‑containing APIs guides both formulation design and shelf‑life prediction.
Designing Modified‑Release Tablets for Steady Plasma Levels
When a drug must maintain therapeutic concentrations for up to 12 hours, a polymeric matrix is the primary design element that ensures a steady release. The matrix controls drug diffusion by creating a viscous gel layer that regulates the rate at which the API migrates into the gastrointestinal fluids.
Types of matrix systems
- Hydrophilic matrices – e.g., hydroxypropyl methylcellulose (HPMC) that swell and form a gel barrier.
- Hydrophobic matrices – e.g., ethylcellulose that slows release by limiting water penetration.
- Mixed‑polymer matrices – combine hydrophilic and hydrophobic polymers to fine‑tune release kinetics.
By adjusting polymer grade, concentration, and tablet geometry, formulators can achieve a near‑zero‑order release profile, minimizing peaks and troughs in plasma concentration.
Conclusion and Key Takeaways
Mastering the interplay between dissolution, permeability, and formulation technology is essential for creating effective drug delivery systems. Remember:
- Increase surface area to boost dissolution speed (Noyes‑Whitney).
- Paracellular diffusion dominates for highly soluble, low‑permeability drugs.
- Superdisintegrants are the linchpin of rapid‑release tablets.
- Higher molecular weight reduces diffusion coefficients, slowing dissolution.
- Adjust the pH of the dissolution medium to simulate gastric conditions.
- Delayed‑release coatings protect acid‑sensitive APIs and target intestinal absorption.
- Ester‑containing drugs require moisture control to prevent hydrolysis.
- Polymeric matrices are the cornerstone of modified‑release tablets that sustain plasma levels for 12 hours or more.
By integrating these principles, pharmaceutical scientists can design dosage forms that achieve optimal therapeutic outcomes while meeting regulatory expectations.
